Sponsors (37)
The bill expands guaranteed dental and vision coverage and federal oversight for Medicaid enrollees with sickle cell disease—improving care access and accountability—while increasing state Medicaid costs, adding reporting obligations, and leaving non‑Medicaid patients without the new benefits.
Medicaid enrollees with sickle cell disease will receive guaranteed dental and vision coverage regardless of state Medicaid comparability rules, expanding access to essential oral and eye care.
States must report quality, access, and total expenditures for enrolled sickle cell patients, creating federal oversight and data to monitor care outcomes and spending.
CMS will publish best practices (by June 30, 2026) informed by clinical guidelines and stakeholders to help states implement effective sickle cell care, improving consistency and care quality.
States that adopt the change will likely face higher Medicaid expenditures to provide dental and vision for people with sickle cell disease, increasing state budget pressure and potential demands on taxpayers.
The amendment applies only to Medicaid enrollees, leaving uninsured and privately insured people with sickle cell disease without the same mandated dental/vision benefits.
Reporting requirements and Secretary-specified measures could create administrative burdens that divert provider, state agency, and health system resources if data collection is onerous or measures are poorly aligned.
Based on analysis of 2 sections of legislative text.
Permits Medicaid health home State plan amendments focused on sickle cell disease and requires dental and vision services and reporting on outcomes, access, and costs.
Official title: To amend title XIX of the Social Security Act to enable State Medicaid programs to provide comprehensive, coordinated care through a health home to individuals with sickle cell disease.
Introduced September 8, 2025 by Neal Patrick Dunn · Last progress September 8, 2025
Allows State Medicaid health home State plan amendments that focus primarily on people with sickle cell disease starting January 1, 2026, and requires states that use this option to provide dental and vision services to those enrollees. States must report on quality, access, and total spending for the targeted population, and the Secretary of HHS will publish best practices by mid-2026 based on clinical guidelines and stakeholder input. Defines who counts as an eligible individual with sickle cell disease for the amendment (Medicaid-eligible and diagnosed by newborn screen or genetic test) and sets reporting and measure-setting responsibilities for the Secretary.